Evidence map›Paper›PMID 34656482›Full record

ReviewJACC. Cardiovascular imaging2022

Cardiovascular Magnetic Resonance for Patients With COVID-19.

Steffen E Petersen, Matthias G Friedrich, Tim Leiner, Matthew D Elias, Vanessa M Ferreira, Maximilian Fenski, Scott D Flamm, Mark Fogel, Ria Garg, Marc K Halushka and 15 more

Abstract readReview
In one paragraph

Review in JACC. Cardiovascular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Prospective electrocardiographic and cardiovascular magnetic resonance alterations in the UK Biobank coronavirus disease 2019 repeat imaging study.Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. MRI of cardiac involvement in COVID-19.The British journal of radiology · 2024
    Review
  18. Article
  19. Coronavirus disease 2019-related hepatic transplant pseudoaneurysm.Journal of vascular surgery cases and innovative techniques · 2024
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Steffen E PetersenWilliam Harvey Research Institute, National Institute for Health Research Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, Barts Health National Health Service Trust, West Smithfield, London, United Kingdom.
Matthias G FriedrichDepartment of Medicine and Diagnostic Radiology, McGill University, Montreal, Quebec, Canada.
Tim LeinerUniversity Medical Center Utrecht, Department of Radiology, Utrecht, the Netherlands; Mayo Clinic, Department of Radiology, Rochester, Minnestoa, USA.
Matthew D EliasDivision of Cardiology, Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Vanessa M FerreiraOxford Centre for Clinical Magnetic Resonance Research, Division of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, Oxford National Institute for Health Research Biomedical Research Centre, University of Oxford, United Kingdom.
Maximilian FenskiUniversitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Working Group on Cardiac Magnetic Resonance, Experimental Clinical Research Centre, Berlin, Germany; Helios Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany; Deutsches Zentrum für Herz-Kreislaufforschung-Partnersite-Berlin, Berlin, Germany.
Scott D FlammCardiovascular Imaging, Imaging and Heart, Vascular, and Thoracic Institutes, Cleveland Clinic, Cleveland, Ohio, USA.
Mark FogelDepartment of Pediatrics (Cardiology) and Radiology, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Department of Radiology, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ria GargDepartment of Medicine and Diagnostic Radiology, McGill University, Montreal, Quebec, Canada.
Marc K HalushkaDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore Maryland, USA.
Allison G HaysDivision of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Nadine Kawel-BoehmDepartment of Radiology, Kantonsspital Graubuenden, Chur, Switzerland; Institute for Diagnostic Interventional Pediatric Radiology, Inselspital, Bern, University Hospital of Bern, Switzerland.
Christopher M KramerCardiovascular Division, Departments of Medicine and Radiology and Medical Imaging, University of Virginia Health System, Charlottesville, Virginia, USA.
Eike NagelInstitute for Experimental and Translational Cardiovascular Imaging, DZHK Center for Cardiovascular Imaging, University Hospital Frankfurt, Frankfurt AM Main, Germany.
Ntobeko A B NtusiDivision of Cardiology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Groote Schuur Hospital, Cape Town, South Africa; Hatter Institute for Cardiovascular Research in Africa, University of Cape Town, Cape Town, South Africa.
Ellen OstenfeldDepartment of Clinical Sciences Lund, Clinical Physiology, Lund University, Lund, Sweden; Skåne University Hospital, Lund, Sweden.
Dudley J PennellNational Heart and Lung Institute, Imperial College, Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, United Kingdom.
Zahra Raisi-EstabraghWilliam Harvey Research Institute, National Institute for Health Research Barts Biomedical Research Centre, Queen Mary University of London, Charterhouse Square, London, United Kingdom; Barts Heart Centre, St Bartholomew's Hospital, Barts Health National Health Service Trust, West Smithfield, London, United Kingdom.
Scott B ReederDepartments of Radiology, Medical Physics, Biomedical Engineering, Medicine, and Emergency Medicine, University of Wisconsin, Madison, Wisconsin, USA.
Carlos E RochitteHeart Institute, InCor, University of São Paulo Medical School and Heart Hospital, Hospital do Coração, São Paulo, Brazil.
Jitka StarekovaDepartment of Radiology, University of Wisconsin, Madison, Wisconsin, USA.
Dominika SucháUniversity Medical Center Utrecht, Department of Radiology, Utrecht, the Netherlands.
Qian TaoDepartment of Imaging Physics, Delft University of Technology, Delft, the Netherlands; Division of Imaging Processing, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Jeanette Schulz-MengerUniversitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Working Group on Cardiac Magnetic Resonance, Experimental Clinical Research Centre, Berlin, Germany; Helios Klinikum Berlin Buch, Department of Cardiology and Nephrology, Berlin, Germany; Deutsches Zentrum für Herz-Kreislaufforschung-Partnersite-Berlin, Berlin, Germany.
David A BluemkeDepartments of Radiology and Medical Physics, University of Wisconsin, Madison, Wisconsin, USA. Electronic address: dbluemke@wisc.edu.

Funding

British Heart Foundation FS/17/81/33318
6 · The paper itself

Abstract

COVID-19 is associated with myocardial injury caused by ischemia, inflammation, or myocarditis. Cardiovascular magnetic resonance (CMR) is the noninvasive reference standard for cardiac function, structure, and tissue composition. CMR is a potentially valuable diagnostic tool in patients with COVID-19 presenting with myocardial injury and evidence of cardiac dysfunction. Although COVID-19-related myocarditis is likely infrequent, COVID-19-related cardiovascular histopathology findings have been reported in up to 48% of patients, raising the concern for long-term myocardial injury. Studies to date report CMR abnormalities in 26% to 60% of hospitalized patients who have recovered from COVID-19, including functional impairment, myocardial tissue abnormalities, late gadolinium enhancement, or pericardial abnormalities. In athletes post-COVID-19, CMR has detected myocarditis-like abnormalities. In children, multisystem inflammatory syndrome may occur 2 to 6 weeks after infection; associated myocarditis and coronary artery aneurysms are evaluable by CMR. At this time, our understanding of COVID-19-related cardiovascular involvement is incomplete, and multiple studies are planned to evaluate patients with COVID-19 using CMR. In this review, we summarize existing studies of CMR for patients with COVID-19 and present ongoing research. We also provide recommendations for clinical use of CMR for patients with acute symptoms or who are recovering from COVID-19.

Indexed as

COVID-19MyocarditisChildContrast MediaGadoliniumHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyPredictive Value of TestsSARS-CoV-2Systemic Inflammatory Response SyndromeContrast MediaGadoliniumcardiovascular magnetic resonanceCOVID-19ischemiamultisystem inflammatory syndromemyocardial injurymyocarditisSARS-CoV-2

Identifiers

PMID34656482
PMCPMC8514168

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.